
LINK . SPRINGER . COM {
}
Title:
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice | Diabetologia
Description:
Aims/hypothesis Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe β/β mice. Methods Apoe β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12 weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Results Treatment of Apoe β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Conclusions/interpretation Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Social Networks
- Science
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We can't figure out the monetization strategy.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {π}
glp, plaque, sitagliptin, article, mice, content, aortic, pubmed, google, scholar, dppiv, cas, diabetes, effects, mmp, macrophage, lesions, treatment, patients, type, migration, collagen, human, levels, root, arch, controls, size, monocyte, cell, cells, study, apoe, inhibition, fig, lesion, germany, highfat, diet, monocytes, glucose, shown, data, reduces, inhibitors, dipeptidyl, peptide, atherosclerosis, activity, glucagonlike,
Topics {βοΈ}
3Β mg h-gly-pro-p-nitroaniline dpp-iv inhibitors des-fluoro-sitagliptin cd26/dipeptidyl-peptidase iv glucose/kg body weight drugs inhibit dpp-iv reduced monocyte/macrophage infiltration dpp-iv activity measurement inhibiting dpp-iv activity western blot analysis dpp-iv inhibitors influence class-matched igg served polyvinylpyrrolidone-free polycarbonate membrane chemokine-induced monocyte migration dpp-iv enzymatic activity plaque monocyte/macrophage content glucose-dependent insulinotropic polypeptide pi3k/akt-dependent pathways dpp-iv substrates include ddp-iv inhibitor treatment random high-power fields apolipoprotein e-deficient mice dpp-iv inhibitor treatment dpp-iv-inhibitor treatment cd8alpha-negative dendritic cells p-myosin light chain human monocyte-derived macrophages primary anti-mac3 antibody goat anti-macrophage-3 antigen des-fluoro-sitagliptin dipeptidyl peptidase-iv dipeptidyl peptidase activity dipeptidyl peptidase-4 inhibitor cell type-specific marker pancreatic beta cells enhancing insulin secretion macrophages reduces atherosclerosis chemokine-induced migration dyslipidemia inhibits toll research diets d12108 plaque macrophage content dpp iv/cd26 plaque macrophage infiltration dpp-iv activity influence vascular chemokine privacy choices/manage cookies dpp-iv inhibitors dpp-iv inhibitor low collagen content monocyte-derived macrophages macrophage mmp-9 production
Questions {β}
- Geelhoed-Duijvestijn PH (2007) Incretins: a new treatment option for type 2 diabetes?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice
description:Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe
β/β mice.
Apoe
β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12Β weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Treatment of Apoe
β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
datePublished:2012-05-18T00:00:00Z
dateModified:2012-05-18T00:00:00Z
pageStart:2267
pageEnd:2275
sameAs:https://doi.org/10.1007/s00125-012-2582-5
keywords:
Atherosclerosis
Glucagon-like peptide-1
Incretins
Plaque stability
Type 2 diabetes
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig5_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice
description:Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe
β/β mice.
Apoe
β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12Β weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Treatment of Apoe
β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
datePublished:2012-05-18T00:00:00Z
dateModified:2012-05-18T00:00:00Z
pageStart:2267
pageEnd:2275
sameAs:https://doi.org/10.1007/s00125-012-2582-5
keywords:
Atherosclerosis
Glucagon-like peptide-1
Incretins
Plaque stability
Type 2 diabetes
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig5_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
External Links {π}(155)
- Discover the revenue of https://www.springernature.com/gp/authors
- How much does https://link.springernature.com/home/ net monthly?
- How much profit does https://order.springer.com/public/cart make?
- Learn how profitable https://mc.manuscriptcentral.com/diabetologia is on a monthly basis
- How much does https://beta.springernature.com/pre-submission?journalId=125 net monthly?
- How much income is https://doi.org/10.1185%2F030079906X162746 earning monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17407649?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20DPP-4%3A%20a%20new%20therapeutic%20approach%20for%20the%20treatment%20of%20type%202%20diabetes&journal=Curr%20Med%20Res%20Opin&doi=10.1185%2F030079906X162746&volume=23&pages=919-931&publication_year=2007&author=Pratley%2CRE&author=Salsali%2CA?
- What are the total earnings of https://doi.org/10.1152%2Fajpendo.00237.2004?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15353407's earnings
- What's http://scholar.google.com/scholar_lookup?&title=Effects%20of%20glucagon-like%20peptide-1%20on%20endothelial%20function%20in%20type%202%20diabetes%20patients%20with%20stable%20coronary%20artery%20disease&journal=Am%20J%20Physiol%20Endocrinol%20Metab&doi=10.1152%2Fajpendo.00237.2004&volume=287&pages=E1209-E1215&publication_year=2004&author=Nystrom%2CT&author=Gutniak%2CMK&author=Zhang%2CQ's gross income?
- What's the income of https://doi.org/10.1016%2Fj.bbrc.2009.10.015?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19850014
- http://scholar.google.com/scholar_lookup?&title=Exendin-4%2C%20a%20GLP-1%20receptor%20agonist%2C%20directly%20induces%20adiponectin%20expression%20through%20protein%20kinase%20A%20pathway%20and%20prevents%20inflammatory%20adipokine%20expression&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2009.10.015&volume=390&pages=613-618&publication_year=2009&author=Kim%20Chung%20le%2CT&author=Hosaka%2CT&author=Yoshida%2CM income
- What are the total earnings of https://doi.org/10.1016%2Fj.peptides.2009.06.019?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19560500
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20protects%20mesenteric%20endothelium%20from%20injury%20during%20inflammation&journal=Peptides&doi=10.1016%2Fj.peptides.2009.06.019&volume=30&pages=1735-1741&publication_year=2009&author=Dozier%2CKC&author=Cureton%2CEL&author=Kwan%2CRO&author=Curran%2CB&author=Sadjadi%2CJ&author=Victorino%2CGP
- How much profit is https://doi.org/10.2337%2Fdiabetes.54.1.146 making per month?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15616022 earning monthly?
- What's http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide%201%20can%20directly%20protect%20the%20heart%20against%20ischemia%2Freperfusion%20injury&journal=Diabetes&doi=10.2337%2Fdiabetes.54.1.146&volume=54&pages=146-151&publication_year=2005&author=Bose%2CAK&author=Mocanu%2CMM&author=Carr%2CRD&author=Brand%2CCL&author=Yellon%2CDM's gross income?
- What is the earnings of https://doi.org/10.1016%2Fj.mce.2010.04.022?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20452396's gross income?
- See how much http://scholar.google.com/scholar_lookup?&title=Exendin-4%20stimulates%20proliferation%20of%20human%20coronary%20artery%20endothelial%20cells%20through%20eNOS-%2C%20PKA-%20and%20PI3K%2FAkt-dependent%20pathways%20and%20requires%20GLP-1%20receptor&journal=Mol%20Cell%20Endocrinol&doi=10.1016%2Fj.mce.2010.04.022&volume=325&pages=26-35&publication_year=2010&author=Erdogdu%2CO&author=Nathanson%2CD&author=Sjoholm%2CA&author=Nystrom%2CT&author=Zhang%2CQ makes per month
- How much does https://doi.org/10.2337%2Fdb09-1618 make?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20368408?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Sitagliptin%20%28MK0431%29%20inhibition%20of%20dipeptidyl%20peptidase%20IV%20decreases%20nonobese%20diabetic%20mouse%20CD4%2B%20T%20cell%20migration%20through%20incretin-dependent%20and%20-independent%20pathways&journal=Diabetes&doi=10.2337%2Fdb09-1618&volume=59&pages=1739-1750&publication_year=2010&author=Kim%2CSJ&author=Nian%2CC&author=McIntosh%2CCH?
- How much does https://doi.org/10.2337%2Fdb08-1101 rake in every month?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19073764 have?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Dipeptidyl%20peptidase%20IV%20inhibition%20with%20MK0431%20improves%20islet%20graft%20survival%20in%20diabetic%20NOD%20mice%20partially%20via%20T%20cell%20modulation&journal=Diabetes&doi=10.2337%2Fdb08-1101&volume=58&pages=641-651&publication_year=2009&author=Kim%2CSJ&author=Nian%2CC&author=Doudet%2CDJ&author=McIntosh%2CCH
- What's the profit of https://doi.org/10.1161%2FCIRCULATIONAHA.111.041418?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22007077 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Long-term%20dipeptidyl-peptidase%204%20inhibition%20reduces%20atherosclerosis%20and%20inflammation%20via%20effects%20on%20monocyte%20recruitment%20and%20chemotaxis&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA.111.041418&volume=124&pages=2338-2349&publication_year=2011&author=Shah%2CZ&author=Kampfrath%2CT&author=Deiuliis%2CJA net monthly?
- What are the earnings of https://doi.org/10.1016%2Fj.vph.2011.05.001?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21664294 have?
- http://scholar.google.com/scholar_lookup?&title=Cardiovascular%20effects%20of%20DPP-4%20inhibition%3A%20beyond%20GLP-1&journal=Vascul%20Pharmacol&doi=10.1016%2Fj.vph.2011.05.001&volume=55&pages=10-16&publication_year=2011&author=Fadini%2CGP&author=Avogaro%2CA's revenue stream
- How much money does https://doi.org/10.1111%2Fj.1742-1241.2006.01246.x generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17156104 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerability%20of%20the%20dipeptidyl%20peptidase-4%20inhibitor%20sitagliptin%20as%20monotherapy%20over%2012%C2%A0weeks%20in%20patients%20with%20type%202%20diabetes&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2006.01246.x&volume=61&pages=171-180&publication_year=2007&author=Scott%2CR&author=Wu%2CM&author=Sanchez%2CM&author=Stein%2CP?
- How profitable is https://doi.org/10.1177%2F0091270008316885?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18353996?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20sitagliptin%2C%20a%20dipeptidyl%20peptidase-4%20inhibitor%2C%20on%20blood%20pressure%20in%20nondiabetic%20patients%20with%20mild%20to%20moderate%20hypertension&journal=J%20Clin%20Pharmacol&doi=10.1177%2F0091270008316885&volume=48&pages=592-598&publication_year=2008&author=Mistry%2CGC&author=Maes%2CAL&author=Lasseter%2CKC?
- How much does https://doi.org/10.1016%2Fj.jacc.2011.07.053 net monthly?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22240132
- Income figures for http://scholar.google.com/scholar_lookup?&title=A%20dipeptidyl%20peptidase-4%20inhibitor%2C%20des-fluoro-sitagliptin%2C%20improves%20endothelial%20function%20and%20reduces%20atherosclerotic%20lesion%20formation%20in%20apolipoprotein%20E-deficient%20mice&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2Fj.jacc.2011.07.053&volume=59&pages=265-276&publication_year=2012&author=Matsubara%2CJ&author=Sugiyama%2CS&author=Sugamura%2CK
- https://doi.org/10.1084%2Fjem.20061737's total income per month
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17296788 is on a monthly basis
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Dyslipidemia%20inhibits%20Toll-like%20receptor-induced%20activation%20of%20CD8alpha-negative%20dendritic%20cells%20and%20protective%20Th1%20type%20immunity&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20061737&volume=204&pages=441-452&publication_year=2007&author=Shamshiev%2CAT&author=Ampenberger%2CF&author=Ernst%2CB&author=Rohrer%2CL&author=Marsland%2CBJ&author=Kopf%2CM?
- https://doi.org/10.5551%2Fjat.13.308's revenue stream
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17192695 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20selective%20NFkappaB%20inhibitor%2C%20DHMEQ%2C%20reduced%20atherosclerosis%20in%20ApoE-deficient%20mice&journal=J%20Atheroscler%20Thromb&doi=10.5551%2Fjat.13.308&volume=13&pages=308-313&publication_year=2006&author=Chiba%2CT&author=Kondo%2CY&author=Shinozaki%2CS bring in?
- https://doi.org/10.2337%2Fdb05-1602's total income per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16731832?
- How much income is http://scholar.google.com/scholar_lookup?&title=Chronic%20inhibition%20of%20dipeptidyl%20peptidase-4%20with%20a%20sitagliptin%20analog%20preserves%20pancreatic%20beta-cell%20mass%20and%20function%20in%20a%20rodent%20model%20of%20type%202%20diabetes&journal=Diabetes&doi=10.2337%2Fdb05-1602&volume=55&pages=1695-1704&publication_year=2006&author=Mu%2CJ&author=Woods%2CJ&author=Zhou%2CYP earning monthly?
- How much profit is https://doi.org/10.1074%2Fjbc.274.48.34053 making per month?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10567372?
- See how much http://scholar.google.com/scholar_lookup?&title=Sequence%2C%20purification%2C%20and%20cloning%20of%20an%20intracellular%20serine%20protease%2C%20quiescent%20cell%20proline%20dipeptidase&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.274.48.34053&volume=274&pages=34053-34058&publication_year=1999&author=Underwood%2CR&author=Chiravuri%2CM&author=Lee%2CH makes per month
- What's the total monthly financial gain of https://doi.org/10.1046%2Fj.1432-1327.2000.01634.x?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10951221 have?
- See how much http://scholar.google.com/scholar_lookup?&title=Molecular%20characterization%20of%20dipeptidyl%20peptidase%20activity%20in%20serum%3A%20soluble%20CD26%2Fdipeptidyl%20peptidase%20IV%20is%20responsible%20for%20the%20release%20of%20X-Pro%20dipeptides&journal=Eur%20J%20Biochem&doi=10.1046%2Fj.1432-1327.2000.01634.x&volume=267&pages=5608-5613&publication_year=2000&author=Durinx%2CC&author=Lambeir%2CAM&author=Bosmans%2CE makes per month
- How profitable is https://doi.org/10.1053%2Fmeta.2003.50014?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12524666 each month?
- See how much http://scholar.google.com/scholar_lookup?&title=Enteroinsular%20axis%20of%20db%2Fdb%20mice%20and%20efficacy%20of%20dipeptidyl%20peptidase%20IV%20inhibition&journal=Metabolism&doi=10.1053%2Fmeta.2003.50014&volume=52&pages=81-86&publication_year=2003&author=Nagakura%2CT&author=Yasuda%2CN&author=Yamazaki%2CK&author=Ikuta%2CH&author=Tanaka%2CI makes per month
- What's the financial outcome of https://doi.org/10.1161%2F01.ATV.0000116027.81513.68?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14707040?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=C-peptide%20colocalizes%20with%20macrophages%20in%20early%20arteriosclerotic%20lesions%20of%20diabetic%20subjects%20and%20induces%20monocyte%20chemotaxis%20in%20vitro&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.0000116027.81513.68&volume=24&pages=540-545&publication_year=2004&author=Marx%2CN&author=Walcher%2CD&author=Raichle%2CC?
- Monthly income for https://doi.org/10.1016%2FS0002-9440%2810%2965540-X
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9665460 have?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Macrophages%20in%20human%20atheroma%20contain%20PPARgamma%3A%20differentiation-dependent%20peroxisomal%20proliferator-activated%20receptor%20gamma%28PPARgamma%29%20expression%20and%20reduction%20of%20MMP-9%20activity%20through%20PPARgamma%20activation%20in%20mononuclear%20phagocytes%20in%20vitro&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2965540-X&volume=153&pages=17-23&publication_year=1998&author=Marx%2CN&author=Sukhova%2CG&author=Murphy%2CC&author=Libby%2CP&author=Plutzky%2CJ
- What's https://doi.org/10.1152%2Fphysrev.00034.2006's gross income?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17928588?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20physiology%20of%20glucagon-like%20peptide%201&journal=Physiol%20Rev&doi=10.1152%2Fphysrev.00034.2006&volume=87&pages=1409-1439&publication_year=2007&author=Holst%2CJJ generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17379930 generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Incretins%3A%20a%20new%20treatment%20option%20for%20type%202%20diabetes%3F&journal=Neth%20J%20Med&volume=65&pages=60-64&publication_year=2007&author=Geelhoed-Duijvestijn%2CPH
- https://doi.org/10.1517%2F14728220903241633's total income per month
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19758106 have monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Glucose%20lowering%20and%20anti-atherogenic%20effects%20of%20incretin-based%20therapies%3A%20GLP-1%20analogues%20and%20DPP-4-inhibitors&journal=Expert%20Opin%20Investig%20Drugs&doi=10.1517%2F14728220903241633&volume=18&pages=1495-1503&publication_year=2009&author=Rizzo%2CM&author=Rizvi%2CAA&author=Spinas%2CGA&author=Rini%2CGB&author=Berneis%2CK produce monthly?
- How much revenue does https://doi.org/10.1016%2Fj.neures.2006.04.008 produce monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16720054?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20inhibits%20LPS-induced%20IL-1beta%20production%20in%20cultured%20rat%20astrocytes&journal=Neurosci%20Res&doi=10.1016%2Fj.neures.2006.04.008&volume=55&pages=352-360&publication_year=2006&author=Iwai%2CT&author=Ito%2CS&author=Tanimitsu%2CK&author=Udagawa%2CS&author=Oka%2CJ?
- Monthly income for https://doi.org/10.1111%2Fj.1365-2133.2008.08515.x
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18384439 generate?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=CD26%2Fdipeptidyl-peptidase%20IV%20in%20psoriatic%20skin%3A%20upregulation%20and%20topographical%20changes&journal=Br%20J%20Dermatol&doi=10.1111%2Fj.1365-2133.2008.08515.x&volume=158&pages=1264-1272&publication_year=2008&author=Lingen%2CRG&author=Kerkhof%2CPC&author=Seyger%2CMM?
- What's the financial intake of https://doi.org/10.1161%2FATVBAHA.108.170548?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18566294
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Low%20tissue%20inhibitor%20of%20metalloproteinases%203%20and%20high%20matrix%20metalloproteinase%2014%20levels%20defines%20a%20subpopulation%20of%20highly%20invasive%20foam-cell%20macrophages&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2FATVBAHA.108.170548&volume=28&pages=1647-1653&publication_year=2008&author=Johnson%2CJL&author=Sala-Newby%2CGB&author=Ismail%2CY&author=Aguilera%2CCM&author=Newby%2CAC?
- How much does https://doi.org/10.1161%2FATVBAHA.111.238402 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22015660 gross monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20tissue%20inhibitor%20of%20metalloproteinase%203%20in%20macrophages%20reduces%20atherosclerosis%20in%20low-density%20lipoprotein%20receptor%20knockout%20mice&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2FATVBAHA.111.238402&volume=32&pages=74-81&publication_year=2012&author=Casagrande%2CV&author=Menghini%2CR&author=Menini%2CS's earnings
- How much does https://doi.org/10.1016%2Fj.vph.2011.03.001 rake in every month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21397040?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Acute%20DPP-4%20inhibition%20modulates%20vascular%20tone%20through%20GLP-1%20independent%20pathways&journal=Vascul%20Pharmacol&doi=10.1016%2Fj.vph.2011.03.001&volume=55&pages=2-9&publication_year=2011&author=Shah%2CZ&author=Pineda%2CC&author=Kampfrath%2CT
- How much does https://doi.org/10.1093%2Feurheartj%2Fehq519 make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21292680 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=Fibroblast%20activation%20protein%20is%20induced%20by%20inflammation%20and%20degrades%20type%20I%20collagen%20in%20thin-cap%20fibroatheromata&journal=Eur%20Heart%20J&doi=10.1093%2Feurheartj%2Fehq519&volume=32&pages=2713-2722&publication_year=2011&author=Brokopp%2CCE&author=Schoenauer%2CR&author=Richards%2CP's earnings
- See how much https://doi.org/10.2174%2F156802611795860933 makes per month
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21510839?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Current%20advances%20and%20therapeutic%20potential%20of%20agents%20targeting%20dipeptidyl%20peptidases-IV%2C%20-II%2C%208%2F9%20and%20fibroblast%20activation%20protein&journal=Curr%20Top%20Med%20Chem&doi=10.2174%2F156802611795860933&volume=11&pages=1447-1463&publication_year=2011&author=Chen%2CSJ&author=Jiaang%2CWT making per month?
- How much profit does https://doi.org/10.2337%2Fdb09-1694 make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20068138 generate?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20monocyte%20adhesion%20to%20endothelial%20cells%20and%20attenuation%20of%20atherosclerotic%20lesion%20by%20a%20glucagon-like%20peptide-1%20receptor%20agonist%2C%20exendin-4&journal=Diabetes&doi=10.2337%2Fdb09-1694&volume=59&pages=1030-1070&publication_year=2010&author=Arakawa%2CM&author=Mita%2CT&author=Azuma%2CK is on a monthly basis
- What's the financial intake of https://doi.org/10.2741%2F2798?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17981666 making per month?
- How much money does http://scholar.google.com/scholar_lookup?&title=SDF-1%20%28CXCL12%29%20in%20haematopoiesis%20and%20leukaemia%3A%20impact%20of%20DPP%20IV%2FCD26&journal=Front%20Biosci&doi=10.2741%2F2798&volume=13&pages=1774-1779&publication_year=2008&author=Hildebrandt%2CM&author=Schabath%2CR make?
- How much does https://doi.org/10.1161%2FCIRCULATIONAHA.107.739938 net monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18427132 income
- How much income does http://scholar.google.com/scholar_lookup?&title=Cardioprotective%20and%20vasodilatory%20actions%20of%20glucagon-like%20peptide%201%20receptor%20are%20mediated%20through%20both%20glucagon-like%20peptide%201%20receptor-dependent%20and%20-independent%20pathways&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA.107.739938&volume=117&pages=2340-2350&publication_year=2008&author=Ban%2CK&author=Noyan-Ashraf%2CMH&author=Hoefer%2CJ&author=Bolz%2CSS&author=Drucker%2CDJ&author=Husain%2CM have?
- Find out how much https://doi.org/10.1001%2Fjama.287.19.2570 earns monthly
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12020339 generate?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Diabetes%20and%20atherosclerosis%3A%20epidemiology%2C%20pathophysiology%2C%20and%20management&journal=JAMA&doi=10.1001%2Fjama.287.19.2570&volume=287&pages=2570-2581&publication_year=2002&author=Beckman%2CJA&author=Creager%2CMA&author=Libby%2CP?
- How profitable is https://doi.org/10.1161%2F01.RES.0000014225.20727.8F?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11934839 earning monthly?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=PPAR%20activators%20as%20antiinflammatory%20mediators%20in%20human%20T%20lymphocytes%3A%20implications%20for%20atherosclerosis%20and%20transplantation-associated%20arteriosclerosis&journal=Circ%20Res&doi=10.1161%2F01.RES.0000014225.20727.8F&volume=90&pages=703-710&publication_year=2002&author=Marx%2CN&author=Kehrle%2CB&author=Kohlhammer%2CK?
- Get to know https://doi.org/10.1056%2FNEJM199901143400207's earnings
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9887164 income
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Atherosclerosis%20%E2%80%93%20an%20inflammatory%20disease&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM199901143400207&volume=340&pages=115-126&publication_year=1999&author=Ross%2CR?
- Get to know what's the income of https://doi.org/10.3810%2Fpgm.2010.05.2138
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20463410 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20systematic%20assessment%20of%20cardiovascular%20outcomes%20in%20the%20saxagliptin%20drug%20development%20program%20for%20type%202%20diabetes&journal=Postgrad%20Med&doi=10.3810%2Fpgm.2010.05.2138&volume=122&pages=16-27&publication_year=2010&author=Frederich%2CR&author=Alexander%2CJH&author=Fiedorek%2CFT rake in every month?
- Find out how much https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2582-5?format=refman&flavour=references earns monthly
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F.%20Vittone
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F.%20Vittone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Liberman make?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Liberman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Vasic
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Vasic%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Ostertag
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Ostertag%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Esser?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Esser%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Walcher is on a monthly basis
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Walcher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Ludwig net monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Ludwig%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Marx
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Marx%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Burgmaier?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Burgmaier%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income does https://s100.copyright.com/AppDispatchServlet?title=Sitagliptin%20reduces%20plaque%20macrophage%20content%20and%20stabilises%20arteriosclerotic%20lesions%20in%20Apoe%20%E2%88%92%2F%E2%88%92%20mice&author=F.%20Vittone%20et%20al&contentID=10.1007%2Fs00125-012-2582-5©right=Springer-Verlag&publication=0012-186X&publicationDate=2012-05-18&publisherName=SpringerNature&orderBeanReset=true have?
- Explore the financials of https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2582-5?format=refman&flavour=citation
- Financial intake of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's financial summary
- What's the financial outcome of https://www.springernature.com/gp/products?
- What's the income of https://www.springernature.com/gp/librarians?
- How much does https://www.springernature.com/gp/societies earn?
- What's the monthly money flow for https://www.springernature.com/gp/partners?
- https://www.springer.com/'s total income per month
- How much revenue does https://www.nature.com/ produce monthly?
- How much does https://www.biomedcentral.com/ make?
- What's the income generated by https://www.palgrave.com/ each month?
- Income figures for https://www.apress.com/
- Profit of https://www.springernature.com/gp/legal/ccpa
- Check the income stats for https://www.springernature.com/gp/info/accessibility
- What's the financial outcome of https://support.springernature.com/en/support/home?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations generate?
- What are the earnings of https://www.springernature.com/?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref